| [1] |
王雪荣. 慢性肾脏病患者冠状动脉钙化与心血管事件、死亡临床相关性研究及Meta分析 [D]. 合肥：安徽医科大学，2019.
|
| [2] |
Wang N, Zhao TT, Li SM, et al. Fibroblast growth factor 21 exerts its anti-inflammatory effects on multiple cell types of adipose tissue in obesity [J]. Obesity (Silver Spring), 2019, 27(3): 399-408.
|
| [3] |
Yan J, Wang J, Huang H, et al. Fibroblast growth factor 21 delayed endothelial replicative senescence and protected cells from H2O2-induced premature senescence through SIRT1 [J]. Am J Transl Res, 2017, 9(10): 4492-4501.
|
| [4] |
Chen A, Liu J, Zhu J, et al. FGF21 attenuates hypoxia induced dysfunction and apoptosis in HPAECs through alleviating endoplasmic reticulum stress [J]. Int J Mol Med, 2018, 42(3): 1684-1694.
|
| [5] |
Jelenik T, Dille M, Müller-Lühlhoff S, et al. FGF21 regulates insulin sensitivity following long-term chronic stress [J]. Mol Metab, 2018, 16: 126-138.
|
| [6] |
Nishimura T, Nakatake Y, Konishi M, et al. Identification of a novel FGF, FGF-21, preferentially expressed in the liver [J]. Biochim Biophys Acta, 2000, 1492(1): 203-206.
|
| [7] |
史雨晨，柳景华. 成纤维细胞生长因子21在大鼠各组织中表达分布的研究 [J]. 心肺血管病杂志，2016, 35(7): 574-577.
|
| [8] |
Muise ES, Azzolina B, Kuo DW, et al. Adipose fibroblast growth factor 21 is up-regulated by peroxisome proliferator-activated receptor gamma and altered metabolic states [J]. Mol Pharmacol, 2008, 74(2): 403-412.
|
| [9] |
Badman MK, Pissios P, Kennedy AR, et al. Hepatic fibroblast growth factor 21 is regulated by PPARalpha and is a key mediator of hepatic lipid metabolism in ketotic states [J]. Cell Metab, 2007, 5(6): 426-437.
|
| [10] |
Goetz R, Beenken A, Ibrahimi OA, et al. Molecular insights into the klotho-dependent, endocrine mode of action of fibroblast growth factor 19 subfamily members [J]. Mol Cell Biol, 2007, 27(9): 3417-3428.
|
| [11] |
Fang Y, Ginsberg C, Sugatani T, et al. Early chronic kidney disease-mineral bone disorder stimulates vascular calcification [J]. Kidney Int, 2014, 85(1): 142-150.
|
| [12] |
王中群，李丽华. 关注血管钙化的起源、演进与转归研究[J]. 中国动脉硬化杂志，2018, 26(11): 1086-1090.
|
| [13] |
Proudfoot D, Skepper JN, Hegyi L, et al. Apoptosis regulates human vascular calcification in vitro: evidence for initiation of vascular calcification by apoptotic bodies [J]. Circ Res, 2000, 87(11): 1055-1062.
|
| [14] |
Clarke MC, Littlewood TD, Figg N, et al. Chronic apoptosis of vascular smooth muscle cells accelerates atherosclerosis and promotes calcification and medial degeneration [J]. Circ Res, 2008, 102(12): 1529-1538.
|
| [15] |
Wu H, Guo H, Liu H, et al. Copper sulfate-induced endoplasmic reticulum stress promotes hepatic apoptosis by activating CHOP, JNK and caspase-12 signaling pathways [J]. Ecotoxicol Environ Saf, 2020, 191: 110236.
|
| [16] |
靳海斌，刘丽君，高波. 内质网应激在成纤维细胞生长因子21抑制大鼠血管钙化过程中的作用[J]. 中国动脉硬化杂志，2019, 27(12): 1032-1036, 1093.
|
| [17] |
Shi Y, Wang S, Peng H, et al. Fibroblast growth factor 21 attenuates vascular calcification by alleviating endoplasmic reticulum stress mediated apoptosis in rats [J]. Int J Biol Sci, 2019, 15(1): 138-147.
|
| [18] |
Datta D, Khatri P, Singh A, et al. Mycobacterium fortuitum-induced ER-mitochondrial calcium dynamics promotes calpain/caspase-12/caspase-9 mediated apoptosis in fish macrophages [J]. Cell Death Discov, 2018, 4: 30.
|
| [19] |
史雨晨，柳景华. 纤维细胞生长因子21对血管钙化大鼠特异性caspase-12凋亡途径作用的研究[J]. 心肺血管病杂志，2021, 40(6): 628-633.
|
| [20] |
Cao F, Liu X, Cao X, et al. Fibroblast growth factor 21 plays an inhibitory role in vascular calcification in vitro through OPG/RANKL system [J]. Biochem Biophys Res Commun, 2017, 491(3): 578-586.
|
| [21] |
Olapoju SO, Adejobi OI, Le Thi X. Fibroblast growth factor 21; review on its participation in vascular calcification pathology [J]. Vascul Pharmacol, 2020, 125-126: 106636.
|
| [22] |
Shi Y, Lu W, Hou Y, et al. Fibroblast growth factor 21 ameliorates vascular calcification by inhibiting osteogenic transition in vitamin D3 plus nicotine-treated rats [J]. Biochem Biophys Res Commun, 2018, 495(4): 2448-2455.
|
| [23] |
马盼飞，王超群，谷明旗，等. 过氧化物酶体增殖物激活受体在肝脏疾病中的作用及分子机制研究进展[J]. 中华消化外科杂志，2019, 18(4): 403-406.
|
| [24] |
付坤，辛毅，史雨晨，等. 成纤维细胞生长因子21对大鼠血管平滑肌钙化的影响及机制[J]. 中华心血管病杂志，2015, 43(10): 879-886.
|
| [25] |
Li X, Yang HY, Giachelli CM. BMP-2 promotes phosphate uptake, phenotypic modulation, and calcification of human vascular smooth muscle cells [J]. Atherosclerosis, 2008, 199(2): 271-277.
|
| [26] |
刘曜蓉，严豪，李振元，等. 磷酸钙晶体通过BMP-2/Smad信号通路促进血管钙化[J]. 中华肾脏病杂志，2018, 34(8): 608-615.
|
| [27] |
覃春美，魏晓，龚财判，等. 血管钙化大鼠肾动脉BMP2/Smad1/Runx2信号通路的表达[J]. 四川大学学报(医学版), 2016, 47(2): 180-183.
|
| [28] |
Liu X, Cao F, Liu S, et al. BMP2/Smad signaling pathway is involved in the inhibition function of fibroblast growth factor 21 on vascular calcification [J]. Biochem Biophys Res Commun, 2018, 503(2): 930-937.
|
| [29] |
Li B, Wang Z, Hu Z, et al. P38 MAPK signaling pathway mediates angiotensin II-induced miR143/145 gene cluster downregulation during aortic dissection formation [J]. Ann Vasc Surg, 2017, 40: 262-273.
|
| [30] |
Cao F, Liu X, Cao X, et al. Fibroblast growth factor 21 plays an inhibitory role in vascular calcification in vitro through OPG/RANKL system [J]. Biochem Biophys Res Commun, 2017, 491(3): 578-586.
|
| [31] |
Ong KL, Campbell S, Wu BJ, et al. Relationship of fibroblast growth factor 21 with subclinical atherosclerosis and cardiovascular events: multi-ethnic study of atherosclerosis [J]. Atherosclerosis, 2019, 287: 46-53.
|
| [32] |
闫燕，李金娥，许玉玲，等. 糖尿病肾病维持性血液透析患者FGF21、β-Klotho水平与颈动脉钙化的关系[J]. 中国中西医结合肾病杂志，2021, 22(5): 414-417.
|
| [33] |
Jiang L, Yin Q, Yang M, et al. Fibroblast growth factor 21 predicts and promotes vascular calcification in haemodialysis patients [J]. Kidney Dis (Basel), 2021, 7(3): 227-240.
|